Lamotrigine in the treatment of depersonalization disorder [2]

Journal of Clinical Psychiatry

Volumn 62, Issue 10, 2001, Pages 826-827

  Sierra, M ^a   Phillips, M L ^a   Lambert, M V ^a   Senior, C ^a   David, A S ^a   Krystal, J H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADD ON THERAPY; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPERSONALIZATION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; TREATMENT OUTCOME;

EID: 0035203926     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1012b     Document Type: Letter

References (13)

1. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
2. Glutamate and post-traumatic stress disorder: Toward a neurobiology of dissociation
3. Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons
4. Lamotrigine attenuates ketamine effects in humans: Support for hyperglutamatergic effects of NMDA antagonists
5. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
6. Development, reliability and validity of a dissociation scale
7. The detection and measurement of depersonalization disorder
8. The spectrum of organic depersonalization: A review of the literature plus four new cases
9. Lamotrigine in the prophylactic treatment of migraine aura: A pilot study
10. Lamotrigine in the treatment of bipolar depression
11. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
12. Lamotrigine as a promising approach to borderline personality: An open case series without concurrent DSM-IV major mood disorder